Does Wellbutrin Increase Anxiety?
Yes, Wellbutrin (bupropion) can increase anxiety in some users. Clinical data shows anxiety as a reported side effect, occurring in about 5% of patients in trials, with higher rates (up to 13-16%) during initial treatment or dose escalation.[1][2] It activates norepinephrine and dopamine pathways, which may heighten arousal or jitteriness mimicking anxiety, unlike SSRIs that often calm it.
Why Does This Happen and Who Is at Risk?
The mechanism ties to bupropion's stimulant-like effects on the central nervous system, potentially worsening baseline anxiety, panic disorders, or conditions like PTSD. Risk factors include starting treatment, higher doses (e.g., 300-450 mg/day), history of anxiety, or combining with caffeine/alcohol. Smokers or those quitting nicotine may notice amplified effects due to bupropion's smoking cessation use (as Zyban).[1][3]
How Long Does Anxiety Last on Wellbutrin?
Symptoms often peak in the first 1-2 weeks as the body adjusts, then subside for most by week 4. Persistent cases may require dose tweaks or discontinuation; studies report resolution in 70-80% without intervention.[2][4] Steady-state levels hit after 5-7 days, so early monitoring is key.
What Do Patients Report?
User forums and post-marketing data highlight "Wellbutrin anxiety" as common, with descriptions of restlessness, racing thoughts, or panic attacks. FDA adverse event reports log over 10,000 anxiety-related cases since approval, though underreporting is likely. Many switch from SSRIs expecting less anxiety but face this trade-off.[5]
Managing or Avoiding Anxiety on Wellbutrin
Start low (150 mg/day), titrate slowly, and pair with therapy or short-term benzodiazepines if prescribed. Alternatives like adding buspirone help some. About 10-20% discontinue due to this side effect.[1][3] Consult a doctor before changes—abrupt stops risk seizures.
How Does Wellbutrin Compare to Other Antidepressants for Anxiety?
Unlike SSRIs/SNRIs (e.g., Zoloft, Effexor), which treat anxiety directly, Wellbutrin lacks FDA anxiety approval and may aggravate it short-term. It's preferred for depression with low sexual side effects or fatigue but avoided in anxiety-primary cases. Trials show 2-3x higher anxiety dropout rates vs. SSRIs.[2][4]
[1]: FDA Label - Wellbutrin XL (https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/021515s049lbl.pdf)
[2]: Journal of Clinical Psychiatry (2006) - Bupropion side effects meta-analysis
[3]: UpToDate - Bupropion pharmacology and adverse effects (https://www.uptodate.com/contents/bupropion-drug-information)
[4]: American Journal of Psychiatry (2011) - Antidepressant tolerability study
[5]: FDA FAERS Database - Bupropion adverse events (https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-latest-quarterly-data-files)